Study: Higher THC levels do not increase schizophrenia rates
Cannabis use has often been accused of triggering schizophrenia. But despite increased THC levels, the number of detected schizophrenia cases is not increasing. Why?
Most cannabis consumers have no problems with their use. A small portion, however, suffers from psychotic symptoms such as paranoia or schizophrenia.
Although several studies suggest that cannabis users are at higher risk of developing schizophrenia, one point remains largely disputed. Since the 1960s, rates of cannabis prevalence and potency have increased, but schizophrenia rates have not.
A recent study, published in the journal Psychological Medicine, can explain that.
1231 cannabis consumers were interviewed about their consumption experience, and a «pleasure score» and «psychotic experience score» were calculated. Based on these scores, they were asked whether they would continue to consume cannabis or if they thought they would stop in the future.
Those who reported the most enjoyment have no intention of stopping. Those, on the other hand, who had unpleasant experiences have either already stopped or are considering doing so in the future. The conclusion is that consumers' experiences with cannabis condition their consumption, regardless of age, sex, mental health history, or other drugs used.
This also suggests that the people at risk are also the ones who quit. Other experiences suggest that schizophrenic individuals have more psychotic episodes when they consume cannabis than non-schizophrenic individuals. And they compensate for their risk of developing schizophrenia by no longer consuming cannabis.
As the author of the study, Musa Sami, points out, these conclusions are only hypotheses that could explain this persistence. around 11:00 a.m. schizophrenia despite the increase in cannabis use. He also highlights the need to focus on the small portion of consumers who continue to use cannabis despite their history or psychotic alerts, even if some consumers who are likely to develop schizophrenia stop.
Via The Conversation
-
Cannabis in Europe4 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange
-
Cannabis in Africa1 week ago
Kenya Denies Rastafarians the Right to Use Cannabis


You must be logged in to post a comment Login